Skip to main content
. 2021 Apr 2;106(8):e2953–e2967. doi: 10.1210/clinem/dgab216

Figure 2.

Figure 2.

Time to mortality for metreleptin-treated versus matched metreleptin-naïve patients (overall cohort). Vertical bars denote censoring events.